139 related articles for article (PubMed ID: 37365116)
1. Hepatocellular adenoma subtyping by qualitative MRI features and machine learning algorithm of integrated qualitative and quantitative features: a proof-of-concept study.
Liu X; Espin-Garcia O; Khalvati F; Namdar K; Fischer S; Haider MA; Jhaveri KS
Clin Radiol; 2023 Sep; 78(9):679-686. PubMed ID: 37365116
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
3. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
4. Subtyping of hepatocellular adenoma: a machine learning-based approach.
Liu Y; Liu YZ; Sun L; Zen Y; Inomoto C; Yeh MM
Virchows Arch; 2022 Jul; 481(1):49-61. PubMed ID: 35389097
[TBL] [Abstract][Full Text] [Related]
5. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
6. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
[TBL] [Abstract][Full Text] [Related]
7. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI.
Michallek F; Sartoris R; Beaufrère A; Dioguardi Burgio M; Cauchy F; Cannella R; Paradis V; Ronot M; Dewey M; Vilgrain V
Insights Imaging; 2022 Apr; 13(1):81. PubMed ID: 35482151
[TBL] [Abstract][Full Text] [Related]
9. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
[No Abstract] [Full Text] [Related]
11. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
Tse JR; Naini BV; Lu DS; Raman SS
Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
13. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
[TBL] [Abstract][Full Text] [Related]
14. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
[TBL] [Abstract][Full Text] [Related]
15. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
17. Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable?
Reizine E; Meurgey A; Amaddeo G; Laurent A; Calderaro J; Mule S; Luciani A
Abdom Radiol (NY); 2022 Jul; 47(7):2347-2355. PubMed ID: 35672475
[TBL] [Abstract][Full Text] [Related]
18. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
Henriet E; Abou Hammoud A; Dupuy JW; Dartigues B; Ezzoukry Z; Dugot-Senant N; Leste-Lasserre T; Pallares-Lupon N; Nikolski M; Le Bail B; Blanc JF; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
Hepatology; 2017 Dec; 66(6):2016-2028. PubMed ID: 28646562
[TBL] [Abstract][Full Text] [Related]
19. Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.
Reizine E; Ronot M; Pigneur F; Purcell Y; Mulé S; Dioguardi Burgio M; Calderaro J; Amaddeo G; Laurent A; Vilgrain V; Luciani A
Eur Radiol; 2019 Jul; 29(7):3791-3801. PubMed ID: 30937584
[TBL] [Abstract][Full Text] [Related]
20. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M
Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
